74 In a comparative study in obese male mice of vertical sleeve gastrectomy (VSG), semaglutide treatment, and controls, both interventions improved glycemic control and reduced body weight, but VSG significantly decreased energy expenditure and induced notable bone loss, whereas semaglutide preserved BMD over six weeks
Collaborations and pharma partnerships for obesity drug development are accelerating innovation, combining expertise to bring next-generation therapies to market faster
Your health journey matters.
Antiplatelets prevent blood cells called platelets from clumping together and forming a clot
PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)
Bradt J, Dileo C, Myers-Coffman K, et al